Glenview Capital Management, LLC Mirati Therapeutics, Inc. Transaction History

Glenview Capital Management, LLC

  • $5.69 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
BUY
$39.16 - $88.71 $3.43 Million - $7.78 Million
87,690 Added 75.52%
203,800 $13.7 Million
Q1 2022

May 16, 2022
BUY
$75.82 - $150.97 $5.33 Million - $10.6 Million
70,310 Added 153.52%
116,110 $9.55 Million
Q3 2021

Nov 15, 2021
BUY
$132.13 - $177.45 $6.05 Million - $8.13 Million
45,800 New
45,800 $8.1 Million

Others Institutions Holding MRTX

# of Institutions
19
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Glenview Capital Management, LLC Portfolio

Follow Glenview Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenview Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glenview Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email